177 related articles for article (PubMed ID: 30536467)
21. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker.
Jin Z; Wang L; Gao H; Zhou YH; Liu YH; Tang YZ
Eur J Med Chem; 2019 Nov; 181():111594. PubMed ID: 31419741
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents.
Zhang Z; Li K; Zhang GY; Tang YZ; Jin Z
Eur J Med Chem; 2020 Oct; 204():112604. PubMed ID: 32731187
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups.
Wang Q; Liu J; Zhou ZD; Zhou KX; Li F; Zhang QW; Wang SK; Wang W; Jin Z; Tang YZ
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2078-2091. PubMed ID: 35875944
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological activity evaluation of a series of pleuromutilin derivatives with novel C14 side chains.
Li YG; Wang JX; Zhang GN; Zhu M; You XF; Wang YC; Zhang F
Bioorg Med Chem Lett; 2020 Apr; 30(7):126969. PubMed ID: 32014384
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, antibacterial activity evaluation and molecular docking study of pleuromutilin derivatives bearing amide side chains.
Zhang ZQ; Liu J; Zhang GY; Li B; Li K; Jin Z; Bai X; Tang YZ
Chem Biol Drug Des; 2022 Oct; 100(4):564-579. PubMed ID: 35730249
[TBL] [Abstract][Full Text] [Related]
26. Pleuromutilin derivatives having a purine ring. Part 3: synthesis and antibacterial activity of novel compounds possessing a piperazine ring spacer.
Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
Bioorg Med Chem Lett; 2009 Jan; 19(1):175-9. PubMed ID: 19022668
[TBL] [Abstract][Full Text] [Related]
27. Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
Bioorg Med Chem Lett; 2008 Jun; 18(12):3556-61. PubMed ID: 18511280
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.
Huang SY; Wang X; Shen DY; Chen F; Zhang GY; Zhang Z; Li K; Jin Z; Du D; Tang YZ
Bioorg Med Chem; 2021 May; 38():116138. PubMed ID: 33857737
[TBL] [Abstract][Full Text] [Related]
29. Antibacterial activity evaluation of pleuromutilin derivatives with 4(3H)-quinazolinone scaffold against methicillin-resistant Staphylococcusaureus.
Deng Y; Zhang Y; Chen XH; Li CH
Eur J Med Chem; 2023 Jan; 246():114960. PubMed ID: 36462445
[TBL] [Abstract][Full Text] [Related]
30. Novel pleuromutilin derivatives with substituted 6-methylpyrimidine: Design, synthesis and antibacterial evaluation.
Fan Y; Liu Y; Wang H; Shi T; Cheng F; Hao B; Yi Y; Shang R
Eur J Med Chem; 2020 Dec; 207():112735. PubMed ID: 32827940
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Biological Evaluation of Novel Thioether Pleuromutilin Derivatives.
Mu S; Liu H; Zhang L; Wang X; Xue F; Zhang Y
Biol Pharm Bull; 2017; 40(8):1165-1173. PubMed ID: 28768998
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of novel pleuromutilin derivatives targeting the 50S ribosomal subunit for antibacterial ability.
Liu Q; Zhang H; Yi Y; Wang P; Pu W; Wang S; Shang R
Eur J Med Chem; 2023 Dec; 262():115882. PubMed ID: 37879170
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of novel pleuromutilin derivatives containing piperazine and 1,2,3-triazole linker.
Zhang GY; Zhang Z; Li K; Liu J; Li B; Jin Z; Liu YH; Tang YZ
Bioorg Chem; 2020 Dec; 105():104398. PubMed ID: 33137559
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antibacterial evaluation of novel pleuromutilin derivatives.
Shang R; Liu Y; Xin Z; Guo W; Guo Z; Hao B; Jianping L
Eur J Med Chem; 2013 May; 63():231-8. PubMed ID: 23501109
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and antibacterial activity of pleuromutilin derivatives.
Liu HX; Yao WY; Cui G; Zhou J; Yan H; Guo H; Wang YW; Zhang Y
Chem Biol Drug Des; 2024 Jun; 103(6):e14554. PubMed ID: 38806405
[TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1
Wang J; Hu YH; Zhou KX; Wang W; Li F; Li K; Zhang GY; Tang YZ
Molecules; 2023 May; 28(9):. PubMed ID: 37175382
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial activity evaluation of synthetic novel pleuromutilin derivatives in vitro and in experimental infection mice.
Deng Y; Wang XZ; Huang SH; Li CH
Eur J Med Chem; 2019 Jan; 162():194-202. PubMed ID: 30445267
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antibacterial activities of novel pleuromutilin derivatives with a substituted pyrimidine moiety.
Yi Y; Xu X; Liu Y; Xu S; Huang X; Liang J; Shang R
Eur J Med Chem; 2017 Jan; 126():687-695. PubMed ID: 27940400
[TBL] [Abstract][Full Text] [Related]
39. Chemical synthesis and biological activities of novel pleuromutilin derivatives with substituted amino moiety.
Shang R; Wang S; Xu X; Yi Y; Guo W; Yuliu ; Liang J
PLoS One; 2013; 8(12):e82595. PubMed ID: 24376551
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of new pleuromutilin derivatives as antibacterial agents.
Shang RF; Wang GH; Xu XM; Liu SJ; Zhang C; Yi YP; Liang JP; Liu Y
Molecules; 2014 Nov; 19(11):19050-65. PubMed ID: 25415471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
